Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Coca-Cola Co K (KO) vs Novavax Inc (NVAX) Price & Performance

The Coca-Cola Co KTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

The Coca-Cola Co K vs Novavax Inc — how do they compare? The Coca-Cola Co K trades at $86.36 (market cap $373.76B), while Novavax Inc trades at $7.95 (market cap $1.30B). The key difference: The Coca-Cola Co K is far larger — about 287.5× Novavax Inc's market cap, and The Coca-Cola Co K pays a 2.44% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

KONVAX
Market Cap
$373.76B$1.30B
Volume
14,630,257
Sector
Consumer StaplesHealth
52-Week High
$89.08$11.19
52-Week Low
$65.67$6.22
Enterprise Value
$400.93B$879.40M
Dividend Yield
2.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Coca-Cola Co K

Coca-Cola (KO) trades at $86.87, down 0.21% on the day, with a bullish technical signal and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $0.97 exceeding the $0.92 forecast. Key valuation ratios include a P/E of 26.09 and ROE of 44.23%, while cash flow trends show robust operational performance. Recent news highlights institutional buying and stable demand trends ahead of Q3 earnings.

The outlook remains positive with a consensus price target of $95.83, implying 10.3% upside. Strengths include a 64-year dividend growth streak and high profitability, but risks involve regional demand divergence and elevated debt levels. Analyst sentiment is bullish with 60% buy ratings, supporting a favorable investment case for long-term holders.

Novavax Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About The Coca-Cola Co K

The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.

Read more on KO

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX